Targeting pathways that modify RNA to deliver novel cancer therapeutics
Targeting pathways that modify RNA to deliver novel cancer therapeutics.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 14, 2022 | Series B | $30M | 8 |
![]() ![]() ![]() ![]() ![]() ![]() |
— | Detail |
May 3, 2022 | Grant | — | 1 |
![]() |
— | Detail |
May 20, 2019 | Series A | £14M | 6 |
![]() |
— | Detail |
Sep 3, 2018 | Grant | £240K | 1 |
![]() |
— | Detail |
Jan 8, 2018 | Series A | £4M | 1 |
![]() |
— | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Series B |
![]() |
Yes | Series B |
![]() |
Yes | Series B |
![]() |
Yes | Series B |
![]() |
Yes | Series B |
![]() |
Yes | Series B |
![]() |
Yes | Grant |
![]() |
— | Series B |
![]() |
— | Series B |
![]() |
— | Series A |